what is the average weekly weight loss on semaglutide Semaglutide: A Weight Loss Breakthrough

There's no safety data

Korner: GLP-1 agonists (commonly referred to as GLP-1s), such as Ozempic and Wegovy, are a class of medications originally designed for diabetic and medically overweight patients

Ozempic face is not an actual side effect or medical condition, but its a commonly reported aesthetic change among people taking GLP-1s

2 Reduced appetite and "food noise": Many patients describe finally being able to stop thinking about food constantly

For example, after two years, people who underwent bariatric surgery had on average a 26.5% reduction in their body weight, compared with 5.7% for those prescribed GLP-1 RAs for any duration